Loading…
Archer Daniels Midland is moving into feed enzyme production, planning an R&D lab in California and a joint development agreement with Qingdao Vland Biotech Group of China. It would compete with BASF and DSM, and ADM already makes fermentation-derived amino acids such as lysine and tryptophan.
This is a corporate strategy move with no immediate supply or price effect on feed ingredients. It may add competition in feed additives over the longer term.
doi.orgMichael McCoyJan 29, 2018Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
